塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/09/28 | 7,310 | 7,436 | 7,300 | 7,424 | +128 | +1.8% | 1,714,800 |
2018/09/27 | 7,256 | 7,432 | 7,231 | 7,296 | +1 | ±0% | 1,471,700 |
2018/09/26 | 7,261 | 7,325 | 7,254 | 7,295 | +55 | +0.8% | 1,298,500 |
2018/09/25 | 7,150 | 7,269 | 7,120 | 7,240 | +79 | +1.1% | 1,625,600 |
2018/09/21 | 7,253 | 7,263 | 7,152 | 7,161 | -22 | -0.3% | 1,759,200 |
2018/09/20 | 7,214 | 7,284 | 7,109 | 7,183 | -33 | -0.5% | 2,073,600 |
2018/09/19 | 7,238 | 7,316 | 7,189 | 7,216 | +92 | +1.3% | 2,069,000 |
2018/09/18 | 6,882 | 7,143 | 6,880 | 7,124 | +278 | +4.1% | 1,749,500 |
2018/09/14 | 6,833 | 6,849 | 6,775 | 6,846 | +113 | +1.7% | 2,173,500 |
2018/09/13 | 6,649 | 6,776 | 6,648 | 6,733 | +156 | +2.4% | 1,598,000 |
2018/09/12 | 6,541 | 6,587 | 6,503 | 6,577 | ±0 | ±0% | 1,050,900 |
2018/09/11 | 6,452 | 6,593 | 6,452 | 6,577 | +115 | +1.8% | 1,573,500 |
2018/09/10 | 6,438 | 6,486 | 6,428 | 6,462 | +25 | +0.4% | 935,000 |
2018/09/07 | 6,420 | 6,452 | 6,366 | 6,437 | +17 | +0.3% | 993,500 |
2018/09/06 | 6,460 | 6,463 | 6,410 | 6,420 | -75 | -1.2% | 938,500 |
2018/09/05 | 6,450 | 6,529 | 6,416 | 6,495 | -2 | ±0% | 1,285,400 |
2018/09/04 | 6,491 | 6,500 | 6,448 | 6,497 | -1 | ±0% | 882,100 |
2018/09/03 | 6,400 | 6,513 | 6,393 | 6,498 | +42 | +0.7% | 962,800 |
2018/08/31 | 6,358 | 6,467 | 6,352 | 6,456 | +103 | +1.6% | 1,649,300 |
2018/08/30 | 6,405 | 6,405 | 6,323 | 6,353 | -13 | -0.2% | 1,043,200 |
2018/08/29 | 6,336 | 6,404 | 6,334 | 6,366 | +59 | +0.9% | 1,274,800 |
2018/08/28 | 6,346 | 6,366 | 6,292 | 6,307 | -38 | -0.6% | 1,241,000 |
2018/08/27 | 6,288 | 6,359 | 6,274 | 6,345 | +87 | +1.4% | 1,124,800 |
2018/08/24 | 6,222 | 6,265 | 6,189 | 6,258 | +9 | +0.1% | 1,086,300 |
2018/08/23 | 6,209 | 6,288 | 6,197 | 6,249 | +86 | +1.4% | 1,288,400 |
2018/08/22 | 6,207 | 6,218 | 6,142 | 6,163 | -48 | -0.8% | 1,072,300 |
2018/08/21 | 6,180 | 6,225 | 6,128 | 6,211 | +62 | +1% | 1,130,100 |
2018/08/20 | 6,189 | 6,189 | 6,111 | 6,149 | -40 | -0.6% | 773,400 |
2018/08/17 | 6,148 | 6,209 | 6,143 | 6,189 | +46 | +0.7% | 979,800 |
2018/08/16 | 6,116 | 6,158 | 6,036 | 6,143 | +4 | +0.1% | 1,191,700 |
2018/08/15 | 6,051 | 6,144 | 6,030 | 6,139 | +66 | +1.1% | 1,050,500 |
2018/08/14 | 5,994 | 6,076 | 5,976 | 6,073 | +103 | +1.7% | 1,114,700 |
2018/08/13 | 6,011 | 6,016 | 5,940 | 5,970 | -70 | -1.2% | 1,037,500 |
2018/08/10 | 6,084 | 6,090 | 6,026 | 6,040 | -17 | -0.3% | 1,147,900 |
2018/08/09 | 6,037 | 6,072 | 6,016 | 6,057 | +20 | +0.3% | 760,900 |
2018/08/08 | 6,046 | 6,077 | 6,011 | 6,037 | -9 | -0.1% | 828,000 |
2018/08/07 | 6,010 | 6,064 | 5,992 | 6,046 | +13 | +0.2% | 808,400 |
2018/08/06 | 6,050 | 6,079 | 6,017 | 6,033 | -18 | -0.3% | 861,800 |
2018/08/03 | 6,074 | 6,089 | 6,020 | 6,051 | -18 | -0.3% | 975,700 |
2018/08/02 | 6,174 | 6,210 | 6,030 | 6,069 | -89 | -1.4% | 1,310,000 |
2018/08/01 | 6,129 | 6,174 | 6,104 | 6,158 | +82 | +1.3% | 1,763,800 |
2018/07/31 | 5,968 | 6,099 | 5,945 | 6,076 | +160 | +2.7% | 3,112,100 |
2018/07/30 | 5,690 | 5,981 | 5,656 | 5,916 | +161 | +2.8% | 2,434,900 |
2018/07/27 | 5,760 | 5,775 | 5,721 | 5,755 | +26 | +0.5% | 784,600 |
2018/07/26 | 5,677 | 5,729 | 5,654 | 5,729 | +79 | +1.4% | 901,600 |
2018/07/25 | 5,742 | 5,756 | 5,639 | 5,650 | -45 | -0.8% | 958,400 |
2018/07/24 | 5,776 | 5,800 | 5,689 | 5,695 | -27 | -0.5% | 937,300 |
2018/07/23 | 5,752 | 5,781 | 5,702 | 5,722 | -29 | -0.5% | 824,700 |
2018/07/20 | 5,741 | 5,787 | 5,702 | 5,751 | +16 | +0.3% | 1,044,700 |
2018/07/19 | 5,765 | 5,778 | 5,731 | 5,735 | +21 | +0.4% | 987,900 |
1501~
1550
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム